- Medical Company
- Medical Company
Improving access to treatments is a priority in Uganda to tackle the surge of chronic diseases. Ugandan patients will soon have better access to Novartis Access medicines targeting cardiovascular disease, diabetes, respiratory illnesses, and breast cancer. The memorandum of understanding was signed today between the Ministry of Health of Uganda and Novartis. Learn more: http://bit.ly/2sRBU1T
From one generation to the next: This week, #NextGenerationScientists alumna Phuti Chelopo talked to the class of 2017 about her experience of working in scientific research. More on the program here: http://bit.ly/2sOBJEp #NextGenScience
#NextGenerationScientists have one thing in common – dedication. This week, Nobel laureate Kurt Wüthrich spoke to them about his own pursuit of scientific discovery. More on the program here: http://bit.ly/2sO63Pz #NextGenScience
What would you ask a Nobel prize winner? On Tuesday, our 2017 #NextGenerationScientists put their questions to Nobel laureate Kurt Wüthrich. More on the program here: http://bit.ly/2ttkoOz #NextGenScience
Thousands of visually impaired people around the world have no access to quality eye health services. This is where XOVA (eXcellence in Ophthalmology Vision Award) helps to make a difference. This year’s XOVA funding has been awarded to excellent projects in Ethiopia Rwanda Tanzania, Uganda and India, helping eye care specialists expanding access to eye care in these regions. #eyecare #accesstohealthcare http://bit.ly/2sClSZF
Today at Basel HQ we’re joined by Nobel prize-winning chemist and biophysicist Kurt Wüthrich. Watch this space to find out what advice he has for our 2017 class of #NextGenerationScientists.
23 talented young scientists from 11 low- and middle-income countries join us for three months this summer at our Basel HQ - learn why: http://bit.ly/2tnycg1
It might seem a tall tale, but Next Generation Scientists 2015 alumnus Edson Barongo Ishengoma used his fascination with giraffes to help shed light on potential therapies for diseases in humans. Learn more. http://bit.ly/2t86eSI
Before we introduce you to this year’s Next Generation Scientists, here’s a throwback to the class of 2016.
Each year, Novartis and the University of Basel invites talented young scientists from developing countries across Africa, Asia and Latin America to our Basel c...ampus for a three-month research internship. One of their first experiences in this program is Welcome Day, a chance to get familiar with their colleagues and get an idea of what it is like to conduct research at Novartis.
See MoreIlana had one single wish: “Please don’t let it be AML…” Read about one nurse’s inspirational journey with AML, a rare and deadly blood cancer, and how she is helping others like her. http://bit.ly/2shBpO1
Though migraine is one of the world’s oldest and most prevalent diseases, it is often confused with “just a headache”. As a result, migraine patients often go undiagnosed. That’s been the case for centuries, but modern medicine is at last catching up with our understanding of the brain.
Breaking news: US FDA approves Novartis targeted therapy option for certain patients with mutation-driven metastatic NSCLC. Read how our continued research is supporting a new treatment option for appropriate patients in the U.S. Read more: http://bit.ly/2svDLrl
According to the Still Fighting For Breath data, almost half of the #asthma patients surveyed self-estimated themselves as having their condition under control, while only 6% have been considered as controlled according to the Global Initiative for Asthma (GINA) clinical guidelines. It’s time for asthma patients to demand more from their asthma treatment and management! #BillionBreaths.
